Fusion Pharmaceuticals Inc.

CIK 1805890 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Fusion Pharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Jun 17, 202415-12G0001193125-24-161987
Jun 7, 2024EFFECT9999999995-24-001776
Jun 7, 2024EFFECT9999999995-24-001778
Jun 7, 2024EFFECT9999999995-24-001777
Jun 5, 202425-NSE0001354457-24-000389
Jun 4, 20248-K0001193125-24-154275
Jun 4, 2024POS AM0001193125-24-154320
Jun 4, 202440000950170-24-068881
Jun 4, 202440000950170-24-068904
Jun 4, 202440000950170-24-068885
Jun 4, 2024S-8 POS0001193125-24-154292
Jun 4, 2024S-8 POS0001193125-24-154298
Jun 4, 2024S-8 POS0001193125-24-154305
Jun 4, 202440000950170-24-068901
Jun 4, 2024POS AM0001193125-24-154314
Jun 4, 202440000950170-24-068892
Jun 4, 202440000950170-24-068879
Jun 4, 202440000950170-24-068889
Jun 4, 202440000950170-24-068867
Jun 4, 2024S-8 POS0001193125-24-154310
Jun 4, 2024S-8 POS0001193125-24-154296
Jun 4, 202440000950170-24-068893
Jun 4, 202440000950170-24-068905
Jun 4, 2024POS AM0001193125-24-154317
Jun 4, 202440000950170-24-068912